Enterprise software deals used to follow a polite script: discovery calls, polished demos, a six-month proof of concept, and three safe reference calls to make the CIO feel comfortable. In the AI era, that script is dead weight. You cannot sell a technology that reinvents itself every ninety days using a procurement process built for the nineties. The traditional enterprise sales cycle is collapsing under three new realities: Hands-on executives. The leaders signing seven-figure checks build with AI on their own laptops over the weekend. When you pitch a roadmap, they are fact-checking your architecture under the conference table. Roadmap obsolescence. A standard enterprise evaluation takes the best part of a year, while AI models leapfrog each other in months. By the time procurement scores the RFP, the requirements they graded are already obsolete. The proof vacuum. Buyers still demand proven production references, yet almost nobody has run these architectures at scale long enough to offer a safe, risk-free blueprint. Welcome to symmetric uncertainty. On the only question that actually closes the deal, which bets will pay off and which will become technical debt, both sides of the table are operating in the dark. When historical proof doesn't exist, enterprise buyers don't buy certainty; they buy a thesis. This book throws out the feature-pitching playbook and replaces it with Thesis-Based Selling. It forces you to think like an investor, take a hard stand on how work is changing, and stress-test that view with your customer: - Lock down the core assumptions driving the buyer's business case before a single feature matrix or demo hits the screen. - Ditch the generic RFP response for a living thesis memo written with the buyer, turning the POC from a vendor bake-off into a joint test of a shared bet. - Put your failure conditions on the table first, showing the technical buyer exactly what evidence would disprove your recommendation, and earning their trust in the process. - Turn AI against your own deal strategy to expose weak assumptions before a skeptical CFO or principal architect tears them apart. Packed with a start-to-finish deal walkthrough, five theses about AI inside companies, and a deal workbook, this framework doesn't replace MEDDIC, SPIN, or The Challenger Sale. It provides the missing strategic engine those methodologies require when the market won't sit still.